CVE-2026-53693MISP BSimVis stored cross-site scripting in tag and cluster rendering paths via unescaped tag metadata and UI labels
Updated under an hour ago ()
Does this affect you?
It affects misp bsimvis. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A stored cross-site scripting vulnerability existed in MISP BSimVis tag rendering code. Several client-side rendering paths interpolated tag names, collection names, entity identifiers, cluster names, and tag metadata directly into HTML, HTML attributes, inline JavaScript event handlers, and CSS style values without context-appropriate escaping. The patch adds shared escaping helpers for HTML, attributes, JavaScript strings, and CSS color validation, then applies them across tag badges, tooltips, context menus, cluster cards, autocomplete suggestions, and dynamically inserted tag cards. An attacker able to create or influence stored tag or metadata values could inject a crafted payload that is later rendered in another user’s browser. Successful exploitation could execute arbitrary JavaScript in the victim’s session when they view affected BSimVis pages, potentially allowing the attacker to perform actions as the victim, read data available to the victim, or alter displayed application content. This issue affects MISP bsimvis: through v0.2.0.
- CVSS
- 6.9 MEDIUM (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:L/SI:N/SA:N
- Weakness (CWE)
- CWE-79, CWE-116
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- CIRCL
- NVD analysis
- Deferred
- Record last updated
- Jun 10, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.